https://doi.org/10.1111/j.1600-6143.2010.03257.x
L
Lisa Murray‐Segal
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
40
Papers
772
Citations
15
h-index
17
i10-index
Lisa Murray‐Segal is an academic researcher from St Vincents Institute of Medical Research. The author has contributed to research in topics: Pancreatic function and diabetes & Metabolism, Diabetes, and Cancer & Tissue Engineering and Regenerative Medicine. The author has an h-index of 15, co-authored 34 publications.
Papers by this author
worksTransgenic Overexpression of CD39 Protects Against Renal Ischemia-Reperfusion and Transplant Vascular Injury
2010 · American Journal of Transplantation · 106 citations
The myokine meteorin‐like (metrnl) improves glucose tolerance in both skeletal muscle cells and mice by targeting AMPKα2
2020 · FEBS Journal · 80 citations
https://doi.org/10.1111/febs.15301
The AMPK activator ATX-304 alters cellular metabolism to protect against cisplatin-induced acute kidney injury
2024 · Biomedicine & Pharmacotherapy · 9 citations
https://doi.org/10.1016/j.biopha.2024.116730
Meteorin-like (Metrnl) adipomyokine improves glucose tolerance in type 2 diabetes via AMPK pathway
2018 · bioRxiv (Cold Spring Harbor Laboratory) · 4 citations
https://doi.org/10.1101/420489
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat